Theyll create a plan thats personalized for you

In Practice for 5 years Attended 2021, Masters , Graduated 2021 License: Florida 25809 / 2025 Education and Years In Practice Additional Credentials Kajol Ghotra Counselor, LMHC Call or Email me for a free 15 minute consultation now - (954) 833-4912 Specialties and Expertise Top Specialties Eating Disorders Obsessive-Compulsive (OCD) Trauma and PTSD Expertise ADHD Anxiety Body Image Borderline Personality (BPD) Child Coping Skills Emotional Disturbance Family Conflict Grief Life Coaching Life Transitions Parenting Personality Disorders Relationship Issues School Issues Self Esteem Stress Substance Use Kajol Ghotra Counselor, LMHC Call or Email me for a free 15 minute consultation now - (954) 833-4912 Endorsement Client Focus Age Children (6 to 10) , Preteen , Teen , Adults Participants Individuals , Couples , Family I also speak Hebrew Age Children (6 to 10) , Preteen , Teen , Adults Participants Individuals , Couples , Family I also speak Hebrew Treatment Approach Types of Therapy Acceptance and Commitment (ACT) Attachment-based Clinical Supervision and Licensed Supervisors Coaching Cognitive Behavioral (CBT) Dialectical Behavior (DBT) Emotionally Focused Exposure Response Prevention (ERP) Family Systems Imago Internal Family Systems (IFS) Person-Centered Prolonged Exposure Therapy Solution Focused Brief (SFBT) Structural Family Therapy Kajol Ghotra Counselor, LMHC Call or Email me for a free 15 minute consultation now - (954) 833-4912 Location Primary Location Elevated Solutions Therapy Royal Palm Beach, FL 33414 (954) 833-4912 Email Me Additional Location 242 West 30th Street New York, NY 10001 (954) 833-4912 Nearby Areas Counties Neighborhoods Kajol Ghotra Counselor, LMHC Call for a free consultation now - (954) 833-4912

Reporting of adverse effects If you get any side effects, talk to your doctor or pharmacist
A comprehensive, consistent approach is the most effective strategy
Mechanistically, these drugs can inhibit the NLRP3 inflammasome and the NF-B pathway, both of which are central drivers of IBD pathology (Bleibel et al., 2025)